Clinical trial
Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
NCT00223951 · Vistakon Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00223951 |
|---|---|
| Title | Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers |
| Official title | A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of R89674 0.25% Ophthalmic Solution in Healthy, Normal Volunteers |
| Lead sponsor | Vistakon Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Healthy Volunteers Eligible for Study, Drug Being Developed for Allergic Conjunctivitis |
| Intervention type | Drug |
| Interventions | R89674 (generic name not yet established) |
| Enrollment | 900 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 20, 2015 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: